Primary information |
---|
ID | 1104 |
Peptide Name | HIV-1 soluble gp41 (sgp41) (539-684) |
Sequence | VQARQLLSGIVQQQNNLLRAIEAQQHLLQLTVWGIKQLQARILAVERYLKDQQLLGIWGCSGKLICTTAVPWNASWSNKSLEQIWNHTTWMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNITNWLWYIKI |
Length | 146 |
Chirality | L |
N-terminal Modification | None |
C-terminal Modification | None |
Chemical Modification | None |
Linear/ Cyclic | Linear |
Nature | Protein Derived |
Source of Origin | HIV-1 isolate IIIB |
Target | NA |
Mechanism of Action | Enhances MHC class I expression |
In vitro/In vivo | In vitro |
Cell Line | Human H9, Jurkat, Raji, Daudi. U937 and HEF cell lines |
Inhibition Concentartion | NA |
In vivo Model | NA |
Assay | NA |
Lethal Dose | NA |
Combination Therapy | NA |
Pubmed ID | 9373217 |
Year of Publication | 1997 |
3-D Structure | View in Jmol or Download Structure |